The patient, who died in July, reportedly used a vaping product containing marijuana that was purchased at a dispensary in Oregon. Ann Thomas, MD, a public health physician at the Oregon Health Authority, declined to share additional information about the patient’s identity, but said the individual was “otherwise healthy and quickly became very ill,” according to NYT.
Dr. Thomas said the patient’s symptoms were consistent with the lung illness that has affected more than 200 people in 25 states. On Aug. 23, health officials confirmed the first death linked to the illnesses in an Illinois patient.
The CDC and FDA are working with state health officials to identify the cause of the illnesses. They discovered the same chemical — vitamin E acetate — in the samples of marijuana products provided by patients nationwide, reports The Washington Post. However, officials say it’s still too early to confirm this contaminant as the definitive source of the illnesses.
More articles on clinical leadership and infection control:
Nurse research prompts care improvements at Providence St. Joseph Health
Eleanor Health opens 1st outpatient addiction clinic in North Carolina
How Cincinnati Children’s cut hospitalization rates 20% among high-risk youth
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.